Annual EBITDA
-$1.61 M
-$771.00 K-91.90%
December 1, 2023
Summary
- As of February 7, 2025, KAPA annual EBITDA is -$1.61 million, with the most recent change of -$771.00 thousand (-91.90%) on December 1, 2023.
- During the last 3 years, KAPA annual EBITDA has fallen by -$564.00 thousand (-53.92%).
- KAPA annual EBITDA is now -91.90% below its all-time high of -$839.00 thousand, reached on December 1, 2022.
Performance
KAPA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$880.00 K
-$679.00 K-337.81%
September 30, 2024
Summary
- As of February 7, 2025, KAPA quarterly EBITDA is -$880.00 thousand, with the most recent change of -$679.00 thousand (-337.81%) on September 30, 2024.
- Over the past year, KAPA quarterly EBITDA has increased by +$195.00 thousand (+18.14%).
- KAPA quarterly EBITDA is now -816.67% below its all-time high of -$96.00 thousand, reached on March 1, 2023.
Performance
KAPA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$2.42 M
-$623.00 K-34.61%
September 30, 2024
Summary
- As of February 7, 2025, KAPA TTM EBITDA is -$2.42 million, with the most recent change of -$623.00 thousand (-34.61%) on September 30, 2024.
- Over the past year, KAPA TTM EBITDA has dropped by -$813.00 thousand (-50.50%).
- KAPA TTM EBITDA is now -1209.73% below its all-time high of -$185.00 thousand, reached on March 1, 2022.
Performance
KAPA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KAPA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.9% | +18.1% | -50.5% |
| 3 y3 years | -53.9% | -375.7% | -1209.7% |
| 5 y5 years | -53.9% | -375.7% | -1209.7% |
KAPA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.9% | +20.6% | -816.7% | +18.1% | -1209.7% | at low |
| 5 y | 5-year | -91.9% | +20.6% | -816.7% | +18.1% | -1209.7% | at low |
| alltime | all time | -91.9% | +20.6% | -816.7% | +18.1% | -1209.7% | at low |
Kairos Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$880.00 K(+337.8%) | -$2.42 M(+34.6%) |
| Jun 2024 | - | -$201.00 K(-24.7%) | -$1.80 M(+1.1%) |
| Mar 2024 | - | -$267.00 K(-75.2%) | -$1.78 M(+10.6%) |
| Dec 2023 | -$1.61 M | -$1.07 M(+318.3%) | -$1.61 M(+135.0%) |
| Sep 2023 | - | -$257.00 K(+41.2%) | -$685.00 K(+13.8%) |
| Jun 2023 | - | -$182.00 K(+89.6%) | -$602.00 K(-19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$96.00 K(-36.0%) | -$750.00 K(-10.6%) |
| Dec 2022 | -$839.00 K(-58.6%) | -$150.00 K(-13.8%) | -$839.00 K(+21.8%) |
| Sep 2022 | - | -$174.00 K(-47.3%) | -$689.00 K(+33.8%) |
| Jun 2022 | - | -$330.00 K(+78.4%) | -$515.00 K(+178.4%) |
| Mar 2022 | - | -$185.00 K | -$185.00 K |
| Dec 2021 | -$2.03 M(+93.8%) | - | - |
| Dec 2020 | -$1.05 M | - | - |
FAQ
- What is Kairos Pharma annual EBITDA?
- What is the all time high annual EBITDA for Kairos Pharma?
- What is Kairos Pharma annual EBITDA year-on-year change?
- What is Kairos Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kairos Pharma?
- What is Kairos Pharma quarterly EBITDA year-on-year change?
- What is Kairos Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for Kairos Pharma?
- What is Kairos Pharma TTM EBITDA year-on-year change?
What is Kairos Pharma annual EBITDA?
The current annual EBITDA of KAPA is -$1.61 M
What is the all time high annual EBITDA for Kairos Pharma?
Kairos Pharma all-time high annual EBITDA is -$839.00 K
What is Kairos Pharma annual EBITDA year-on-year change?
Over the past year, KAPA annual EBITDA has changed by -$771.00 K (-91.90%)
What is Kairos Pharma quarterly EBITDA?
The current quarterly EBITDA of KAPA is -$880.00 K
What is the all time high quarterly EBITDA for Kairos Pharma?
Kairos Pharma all-time high quarterly EBITDA is -$96.00 K
What is Kairos Pharma quarterly EBITDA year-on-year change?
Over the past year, KAPA quarterly EBITDA has changed by +$195.00 K (+18.14%)
What is Kairos Pharma TTM EBITDA?
The current TTM EBITDA of KAPA is -$2.42 M
What is the all time high TTM EBITDA for Kairos Pharma?
Kairos Pharma all-time high TTM EBITDA is -$185.00 K
What is Kairos Pharma TTM EBITDA year-on-year change?
Over the past year, KAPA TTM EBITDA has changed by -$813.00 K (-50.50%)